ESR-LOGOS REIT secures 20-year master lease for 3 Tuas South Ave 4

PharmaGend Global Medical Services is the lessee.

ESR-LOGOS REIT (E-LOG)has inked a 20-year master lease with PharmaGend Global Medical Services (PharmaGend) at 3 Tuas South Ave 4.

In a bourse filing, the REIT said the master lease represents a “|contribution of approximately 1.0% of E-LOG’s portfolio rental income as of 30 September 2023.”

The lease also extends E-LOG’s weighted average lease expiry (WALE) from 3.4 years to 3.5 years and represents a positive rental growth of over 35% over the previous lease.

3 Tuas South Ave 4 is a three-storey pharmaceutical manufacturing facility located at the entrance of Tuas Biomedical Park.

The property has a gross floor area of 29,449 sqm and sits on a land area of 59,708 sqm, with an unutilised plot ratio providing an additional c.19,000 sqm of potential gross floor area for future expansion and has a remaining land tenure of 35.3 years.

Follow the link for more news on

ESR-REIT

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia